Clinical Trials Browser

Burkitt Lymphoma, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, Large B-Cell, Diffuse, Lymphoma, B-Cell, Marginal Zone, Lymphoma, Mantle-Cell

NCT07280494 2025-12-12

S101MRD

Phase 1 Recruiting

18 enrolled

Lymphoid

Lymphoma, Neoplasm, Residual

NCT06649227 2025-12-05

CARLA-M19

Phase 1 Recruiting

5 enrolled

Other hematologic neoplasm

Recurrence, Leukemia, Myeloid, Acute

NCT07053670 2025-11-17

CT1190B

Phase 1 Recruiting

27 enrolled

Lymphoid

Lymphoma, B-Cell

NCT07231081 2025-11-17

Phase I Study of TX103 CAR-T Cells in Participants With Advanced Solid Tumors

Phase 1 Recruiting

85 enrolled

Other solid neoplasm

Solid Tumors

NCT02917083 2025-07-25

RELY-30

Phase 1 Recruiting

60 enrolled

Lymphoid

Hodgkin Disease, Lymphoma, Lymphoma, Non-Hodgkin

NCT05225363 2025-07-01

Modified Immune Cells (TAG72-CAR T Cells) for the Treatment of Patients With Platinum Resistant Epithelial Ovarian Cancer

Phase 1 Recruiting

33 enrolled

Gynecologic

Platinum-Resistant Ovarian Carcinoma

NCT06815029 2025-06-26

Intracranial Genetically Modified Immune Cells (TGFβR2KO/IL13Rα2 CAR T-Cells) for the Treatment of Recurrent or Progressive Glioblastoma or Grade 3 or 4 IDH-Mutant Astrocytoma

Phase 1 Recruiting

27 enrolled

CNSLymphoid

Astrocytoma, Glioblastoma, Lymphoma, Follicular

NCT06822868 2025-02-12

CT1190B

Phase 1 Recruiting

24 enrolled

Lymphoid

Lymphoma, B-Cell

NCT06734871 2025-01-03

CT1190B

Phase 1 Recruiting

24 enrolled

Lymphoid

Lymphoma, B-Cell

NCT06752785 2024-12-31

CD19/CD22 CAR-T Cell Therapy in MRD-Positive B-lineage Acute Lymphoblastic Leukemia in Children.

Phase 1 Recruiting

10 enrolled

LymphoidOther hematologic neoplasm

Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT05779917 2024-06-25

Mesothelin/GPC3/GUCY2C-CAR-T Cells Against Cancers

Phase 1 Recruiting

30 enrolled

Gastrointestinal

Pancreatic Neoplasms

NCT05268172 2024-05-16

IFN-γ Combined With T Cells in the Treatment of Refractory Malignant Pleural Effusion and Ascites

Phase 1 Recruiting

40 enrolled

Thoracic

Pleural Effusion, Malignant

NCT05052528 2024-05-13

Fludarabine and Cyclophosphamide With or Without Rituximab Before CD19 Chimeric Antigen Receptor T Cells for the Treatment of Relapsed or Refractory Diffuse Large B-Cell Lymphoma

Phase 1 Recruiting

36 enrolled

Lymphoid

Lymphoma, Large B-Cell, Diffuse

NCT05354375 2022-04-29

Clinical Study of PSMA-targeted CAR-T Cells in the Treatment of Castration-resistant Prostate Cancer

Phase 1 Recruiting

20 enrolled

Immunotherapy

NCT05043571 2021-09-14

CARTALL: Chimeric-Antigen Receptor (CAR) T-Cell Therapy for Relapsed/ Refractory T-Lineage Acute Lymphoblastic Leukaemia

Phase 1 Recruiting

20 enrolled

LymphoidOther hematologic neoplasm

Leukemia, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Precursor T-Cell Lymphoblastic Leukemia-Lymphoma

NCT05038696 2021-09-09

ALaCART

Phase 1 Recruiting

40 enrolled

LymphoidOther hematologic neoplasm

Precursor Cell Lymphoblastic Leukemia-Lymphoma